Nuclear Medicine and Biology
Volume 37, Issue 1 , Pages 57-65 , January 2010

An improved synthesis and biological evaluation of a new cage-like bifunctional chelator, 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo[6.6.6]icosane-1-ylamino)methyl)benzoic acid, for 64Cu radiopharmaceuticals

Received 19 July 2009 ,Revised 29 August 2009 ,Accepted 1 September 2009.

References 

  1. Tanaka K, Fukase K. PET (positron emission tomography) imaging of biomolecules using metal-DOTA complexes: a new collaborative challenge by chemists, biologists, and physicians for future diagnostics and exploration of in vivo dynamics. Org Biomol Chem. 2008;6:815–828
  2. Wu AM. Antibodies and antimatter: the resurgence of immuno-PET. J Nucl Med. 2009;50:2–5
  3. Nayak TK, Brechbiel MW. Radioimmunoimaging with longer-lived positron-emitting radionuclides: potentials and challenges. Bioconjug Chem. 2009;20:825–841
  4. Wadas TJ, Wong EH, Weisman GR, Anderson CJ. Copper chelation chemistry and its role in copper radiopharmaceuticals. Curr Pharm Des. 2007;13:3–16
  5. Smith SV. Molecular imaging with copper-64. J Inorg Biochem. 2004;98:1874–1901
  6. Blower PJ, Lewis JS, Zweit J. Copper radionuclides and radiopharmaceuticals in nuclear medicine. Nucl Med Biol. 1996;23:957–980
  7. Liu S. Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides. Adv Drug Deliv Rev. 2008;60:1347–1370
  8. Ferreira CL, Yapp DT, Lamsa E, Gleave M, Bensimon C, Jurek P, et al. Evaluation of novel bifunctional chelates for the development of Cu-64-based radiopharmaceuticals. Nucl Med Biol. 2008;35:875–882
  9. Gasser G, Tjioe L, Graham B, Belousoff MJ, Juran S, Walther M, et al. Synthesis, copper(II) complexation, 64Cu-labeling, and bioconjugation of a new bis(2-pyridylmethyl) derivative of 1,4,7-triazacyclononane. Bioconjug Chem. 2008;19:719–730
  10. Juran S, Walther M, Stephan H, Bergmann R, Steinbach J, Kraus W, et al. Hexadentate bispidine derivatives as versatile bifunctional chelate agents for copper(II) radioisotopes. Bioconjug Chem. 2009;20:347–359
  11. Smith SV. SarAr technology for the application of copper-64 in biology and materials science. Q J Nucl Med Mol Imaging. 2008;52:193–202
  12. Wei L, Ye Y, Wadas TJ, Lewis JS, Welch MJ, Achilefu S, et al. 64Cu-Labeled CB-TE2A and diamsar-conjugated RGD peptide analogs for targeting angiogenesis: comparison of their biological activity. Nucl Med Biol. 2009;36:277–285
  13. Cai H, Fissekis J, Conti PS. Synthesis of a novel bifunctional chelator AmBaSar based on sarcophagine for peptide conjugation and 64Cu radiolabeling. Dalton Trans. 2009;5395–5400
  14. Voss SD, Smith SV, DiBartolo N, McIntosh LJ, Cyr EM, Bonab AA, et al. Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. Proc Natl Acad Sci U S A. 2007;104:17489–17493
  15. Di Bartolo N, Sargeson AM, Smith SV. New 64Cu PET imaging agents for personalised medicine and drug development using the hexa-aza cage, SarAr. Org Biomol Chem. 2006;4:3350–3357
  16. Di Bartolo N, Sargeson AM, Donlevy TM, Smith SV. Synthesis of a new cage ligand, SarAr, and its complexation with selected transition metal ions for potential use in radioimaging. J Chem Soc, Dalton Trans. 2001;2001:2303–2309
  17. Yeh GC, Beatty AM, Bashkin JK. Synthesis and characterization of cobalt-cage complexes with pendant phenol groups. Inorg Chem. 1996;35:3828–3835
  18. Chen X, Hou Y, Tohme M, Park R, Khankaldyyan V, Gonzales-Gomez I, et al. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor αvβ3-integrin expression. J Nucl Med. 2004;45:1776–1783
  19. Chen X, Park R, Tohme M, Shahinian AH, Bading JR, Conti PS. MicroPET and autoradiographic imaging of breast cancer alpha v-integrin expression using 18F- and 64Cu-labeled RGD peptide. Bioconjug Chem. 2004;15:41–49
  20. Prasanphanich AF, Retzloff L, Lane SR, Nanda PK, Sieckman GL, Rold TL, et al. In vitro and in vivo analysis of [64Cu-NO2A-8-Aoc-BBN(7–14)NH2]: a site-directed radiopharmaceutical for positron-emission tomography imaging of T-47D human breast cancer tumors. Nucl Med Biol. 2009;36:171–181

☆ This work was supported by the USC Department of Radiology and the Provost's Biomedical Imaging Science Initiative.

PII: S0969-8051(09)00224-8

doi: 10.1016/j.nucmedbio.2009.09.001

Nuclear Medicine and Biology
Volume 37, Issue 1 , Pages 57-65 , January 2010

Article Tools

* Image Usage & Resolution